LOGIN  |  REGISTER
C4 Therapeutics

OrthoPediatrics Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case

August 01, 2025 | Last Trade: US$18.31 0.03 0.16

WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip System, used to treat proximal femur fractures and deformities.

“The 3P Pediatric Plating Platform Hip System is an exceptional product that would not be possible without our remarkable design surgeons and development teams. By harnessing their insights and leveraging next-generation hardware, this system offers surgeons improved precision with additional fixation options. The demand being placed on implants continues to evolve, by addressing these new unmet needs while building upon this 3rd generation system will improve proximal femur care options,” said OrthoPediatrics Trauma and Deformity and OPSB division President, Joe Hauser commented.

CEO, David Bailey added, “This launch marks our inaugural Pediatric Plating Platform and underscores our commitment to expanding the platform into the most comprehensive plating portfolio in pediatric orthopedics.”

Part of the Trauma & Deformity Correction suite of products, the comprehensive 3P Hip System includes a Beam Screw construct and Locking Proximal Femur Plates available in Infant, Child, and Adolescent sizes. The 3P Hip System integrates advanced implant and instrument technology to support both trauma and deformity surgeries, giving surgeons unmatched precision and a complete array of fixation options for proximal femur procedures. The first surgical case for the 3P Pediatric Plating Platform Hip System utilizing the Beam Screw construct has been completed with overwhelmingly positive feedback. Following the system launch, more than 10 cases were booked in August alone, with procedural volume expected to grow substantially in the coming months.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
This email address is being protected from spambots. You need JavaScript enabled to view it. 
415-937-5406

Assertio

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page